Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Journey Medical Corporation (DERM : NSDQ)

• Company Description    Journey Medical Corporation is a commercial-stage pharmaceutical company. It focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Journey Medical Corporation is based in Scottsdale, Arizona. Number of Employees: 58

• Price / Volume Information    Yesterday's Closing Price: $5.96 Daily Weekly Monthly 20 Day Moving Average: 269,651 shares Shares Outstanding: 27.33 (millions) Market Capitalization: $162.89 (millions) Beta: 1.03 52 Week High: $9.56 52 Week Low: $4.31 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 16.18% 10.50% 12 Week -31.57% -36.74% Year To Date -22.70% -25.95%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 9237 E VIA DE VENTURA BLVD. SUITE 105 - SCOTTSDALE,AZ 85258 USA ph: 480-434-6670 fax: - ir@jmcderm.com http://www.jmcderm.com

• General Corporate Information    Officers Claude Maraoui - Chief Executive Officer; President and Director Lindsay A. Rosenwald - Executive Chairman Joseph Benesch - Chief Financial Officer Neil Herskowitz - Director Justin Smith - Director Peer Information Journey Medical Corporation (GSAC) Journey Medical Corporation (CASIF) Journey Medical Corporation (ALCD.) Journey Medical Corporation (OMNN) Journey Medical Corporation (CGPI.) Journey Medical Corporation (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 48115J109 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/11/26 Share - Related Items Shares Outstanding: 27.33 Most Recent Split Date: (:1) Beta: 1.03 Market Capitalization: $162.89 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.00 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.17 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/11/26

• Fundamental Ratios P/E Current FY Estimate: 34.06 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 5.28 Price/Cash Flow: - Price / Sales: 2.52 EPS Growth vs. Year Ago Period: 55.56% vs. Previous Quarter: -100.00% Sales Growth vs. Year Ago Period: 21.48% vs. Previous Quarter: -0.73% ROE 03/31/26 - -35.57 12/31/25 - -46.40 09/30/25 - -39.94 ROA 03/31/26 - -10.88 12/31/25 - -13.22 09/30/25 - -10.45 Current Ratio 03/31/26 - 1.72 12/31/25 - 1.79 09/30/25 - 1.42 Quick Ratio 03/31/26 - 1.47 12/31/25 - 1.53 09/30/25 - 1.12 Operating Margin 03/31/26 - -14.82 12/31/25 - -18.48 09/30/25 - -14.58 Net Margin 03/31/26 - -14.82 12/31/25 - -18.48 09/30/25 - -14.58 Pre-Tax Margin 03/31/26 - -14.73 12/31/25 - -18.38 09/30/25 - -14.38 Book Value 03/31/26 - 1.13 12/31/25 - 0.96 09/30/25 - 0.98 Inventory Turnover 03/31/26 - 2.05 12/31/25 - 1.79 09/30/25 - 1.56 Debt-to-Equity 03/31/26 - 0.74 12/31/25 - 0.79 09/30/25 - 0.75 Debt-to-Capital 03/31/26 - 42.59 12/31/25 - 44.24 09/30/25 - 43.00

Powered by Zacks Investment Research ©